58 related articles for article (PubMed ID: 10782413)
1. Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors.
Shimizu M; Toki T; Takagi Y; Konishi I; Fujii S
Int J Gynecol Pathol; 2000 Apr; 19(2):158-63. PubMed ID: 10782413
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma.
Oji Y; Yamamoto H; Nomura M; Nakano Y; Ikeba A; Nakatsuka S; Abeno S; Kiyotoh E; Jomgeow T; Sekimoto M; Nezu R; Yoshikawa Y; Inoue Y; Hosen N; Kawakami M; Tsuboi A; Oka Y; Ogawa H; Souda S; Aozasa K; Monden M; Sugiyama H
Cancer Sci; 2003 Aug; 94(8):712-7. PubMed ID: 12901797
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma.
Oji Y; Nakamori S; Fujikawa M; Nakatsuka S; Yokota A; Tatsumi N; Abeno S; Ikeba A; Takashima S; Tsujie M; Yamamoto H; Sakon M; Nezu R; Kawano K; Nishida S; Ikegame K; Kawakami M; Tsuboi A; Oka Y; Yoshikawa K; Aozasa K; Monden M; Sugiyama H
Cancer Sci; 2004 Jul; 95(7):583-7. PubMed ID: 15245594
[TBL] [Abstract][Full Text] [Related]
4. Late-Stage Ovarian Cancer With Systemic Multiple Metastases Shows Marked Shrinkage Using a Combination of Wilms' Tumor Antigen 1 (WT1) Dendritic Cell Vaccine, Natural Killer (NK) Cell Therapy, and Nivolumab.
Nagai H; Karube R
Cureus; 2024 Mar; 16(3):e56685. PubMed ID: 38523872
[TBL] [Abstract][Full Text] [Related]
5. WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium.
Acs G; Pasha T; Zhang PJ
Int J Gynecol Pathol; 2004 Apr; 23(2):110-8. PubMed ID: 15084838
[TBL] [Abstract][Full Text] [Related]
6. Potential Markers to Differentiate Uterine Leiomyosarcomas from Leiomyomas.
Guo J; Zheng J; Tong J
Int J Med Sci; 2024; 21(7):1227-1240. PubMed ID: 38818470
[TBL] [Abstract][Full Text] [Related]
7. Histopathological Evaluation and Molecular Diagnostic Tests for Peritoneal Metastases with Unknown Primary Site-a Review.
Bhatt A; Mishra S; Glehen O
Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):15-29. PubMed ID: 37359927
[TBL] [Abstract][Full Text] [Related]
8. Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission.
Manning-Geist BL; Gnjatic S; Aghajanian C; Konner J; Kim SH; Sarasohn D; Soldan K; Tew WP; Sarlis NJ; Zamarin D; Kravetz S; Laface I; Rasalan-Ho T; Qi J; Wong P; Sabbatini PJ; O'Cearbhaill RE
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900251
[TBL] [Abstract][Full Text] [Related]
9. A Novel HAGE/WT1-ImmunoBody
Almshayakhchi R; Nagarajan D; Vadakekolathu J; Guinn BA; Reeder S; Brentville V; Metheringham R; Pockley AG; Durrant L; McArdle S
Front Oncol; 2021; 11():636977. PubMed ID: 34262856
[TBL] [Abstract][Full Text] [Related]
10. Single-cell transcriptomics identifies gene expression networks driving differentiation and tumorigenesis in the human fallopian tube.
Dinh HQ; Lin X; Abbasi F; Nameki R; Haro M; Olingy CE; Chang H; Hernandez L; Gayther SA; Wright KN; Aspuria PJ; Karlan BY; Corona RI; Li A; Rimel BJ; Siedhoff MT; Medeiros F; Lawrenson K
Cell Rep; 2021 Apr; 35(2):108978. PubMed ID: 33852846
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Review of Ovarian Serous Carcinoma.
Hatano Y; Hatano K; Tamada M; Morishige KI; Tomita H; Yanai H; Hara A
Adv Anat Pathol; 2019 Sep; 26(5):329-339. PubMed ID: 31368906
[TBL] [Abstract][Full Text] [Related]
12. Utilization of Wilms' tumor 1 antigen in a panel for differential diagnosis of ovarian carcinomas.
Şakirahmet Şen D; Gökmen Karasu AF; Özgün Geçer M; Karadayı N; Ablan Yamuç E
Turk J Obstet Gynecol; 2016 Mar; 13(1):37-41. PubMed ID: 28913087
[TBL] [Abstract][Full Text] [Related]
13. Molecular determination of the clonal relationships between multiple tumors in BRCA1/2-associated breast and/or ovarian cancer patients is clinically relevant.
Geurts-Giele WR; van Verschuer VM; van Deurzen CH; van Diest PJ; Pedrosa RM; Collée JM; Koppert LB; Seynaeve C; Dinjens WN
Mod Pathol; 2017 Jan; 30(1):15-25. PubMed ID: 27612322
[TBL] [Abstract][Full Text] [Related]
14. WT1 expression is increased in primary fibroblasts derived from Dupuytren's disease tissues.
Crawford J; Raykha C; Charles D; Gan BS; O'Gorman DB
J Cell Commun Signal; 2015 Dec; 9(4):347-52. PubMed ID: 26123754
[TBL] [Abstract][Full Text] [Related]
15. Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR).
McCluggage WG; Judge MJ; Clarke BA; Davidson B; Gilks CB; Hollema H; Ledermann JA; Matias-Guiu X; Mikami Y; Stewart CJ; Vang R; Hirschowitz L;
Mod Pathol; 2015 Aug; 28(8):1101-22. PubMed ID: 26089092
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor gene 1 regulates p63 and promotes cell proliferation in squamous cell carcinoma of the head and neck.
Li X; Ottosson S; Wang S; Jernberg E; Boldrup L; Gu X; Nylander K; Li A
BMC Cancer; 2015 May; 15():342. PubMed ID: 25929687
[TBL] [Abstract][Full Text] [Related]
17. The Wilms' Tumor Gene WT1 - 17AA/- KTS Splice Variant Increases Tumorigenic Activity Through Up-Regulation of Vascular Endothelial Growth Factor in an In Vivo Ovarian Cancer Model.
Yamanouchi K; Ohta T; Liu Z; Oji Y; Sugiyama H; Shridhar V; Matsumura S; Takahashi T; Takahashi K; Kurachi H
Transl Oncol; 2014 Oct; 7(5):580-9. PubMed ID: 25389453
[TBL] [Abstract][Full Text] [Related]
18. Tumors that mimic asbestos-related mesothelioma: time to consider a genetics-based tumor registry?
Kerger BD; James RC; Galbraith DA
Front Genet; 2014; 5():151. PubMed ID: 24910640
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of specific anti-WT1 IgG antibody level in plasma in patients with ovarian carcinoma.
Andersson C; Oji Y; Ohlson N; Wang S; Li X; Ottander U; Lundin E; Sugiyama H; Li A
Cancer Med; 2014 Aug; 3(4):909-18. PubMed ID: 24715586
[TBL] [Abstract][Full Text] [Related]
20. Predictive and prognostic protein biomarkers in epithelial ovarian cancer: recommendation for future studies.
Le Page C; Huntsman DG; Provencher DM; Mes-Masson AM
Cancers (Basel); 2010 May; 2(2):913-54. PubMed ID: 24281100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
